logo

For the Inventor, By the Inventor

West Chester, PA, United States of America

Kenneth L Kees

This inventor holds 13 USPTO granted patents. Top assignees: American Home Products Corporation, Wyeth. Active years: 1985-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth L Kees. Retrieved from https://idiyas.com/inventor/kenneth-l-kees

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 92.3

Average Co-Inventor Count = 1.4

ph-index = 7

Forward Citations = 104(Granted Patents)


Location History:

  • West Chester, PA (US) (1985 - 1989)
  • Plainsboro, NJ (US) (1993)
  • Glennmoore, PA (US) (1997)
  • Glenmoore, PA (US) (2001 - 2010)

Company Filing History:

goldMedal11 out of 1,567 
 
American Home Products Corporation
 patents
silverMedal2 out of 1,309 
 
Wyeth
 patents

Years Active: 1985-2010

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7696210 - Gonadotropin releasing hormone receptor antagonists (2010-04-13),
2. 6429214 - Bicyclic antagonists selective for the &agr;v&bgr;3 integrin (2002-08-06),
3. 6281234 - (2-Acylaminothiazole-4-yl)acetic acid derivative (2001-08-28),
4. 5688821 - Unsaturated fatty acyl derivatives of 2-aminothiazoleacetic acid and (1997-11-18),
5. 5274111 - Trifluoromethyl substituted 1H-pyrazoles and derivatives thereof (1993-12-28),
6. 5264451 - Process for treating hyperglycemia using trifluoromethyl substituted (1993-11-23),
7. 5194435 - 4-arylmethyl-5-alkyl-3h-pyrazol-3-ones (1993-03-16),
8. 5183825 - 4-arylmethyl-5-alkyl-3H-pyrazol-3-ones and hypoglycemic use (1993-02-02),
9. 4845231 - Tetrazoles and their use as hypoglycemic agents (1989-07-04),
10. 4764623 - N-(1H-tetrazol-5-yl-alkylphenyl)polyfluoroalkanamides (1988-08-16),
11. 4732978 - Novel substituted naphthyloxymethyl quinoline derivatives as (1988-03-22),
12. 4728739 - Hypoglycemic thiazolidinediones (1988-03-01),
13. 4528392 - Aromatic compounds as antiallergic agents (1985-07-09),

Title: Kenneth L Kees: Innovator in Hormonal Research

Introduction

Kenneth L Kees is a notable inventor based in West Chester, PA (US), recognized for his contributions to the field of hormonal research. With a total of 13 patents, Kees has made significant advancements in the development of compounds that target hormonal receptors.

Latest Patents

Among his latest patents, Kees has developed Gonadotropin releasing hormone receptor antagonists. These compounds, classified under Formula I, are useful as Gonadotropin Releasing Hormone (GnRH) receptor antagonists, which play a crucial role in hormonal regulation. Additionally, he has worked on bicyclic antagonists that are selective for the αvβ3 integrin, further showcasing his innovative approach to hormonal therapies.

Career Highlights

Throughout his career, Kenneth L Kees has been associated with prominent companies such as American Home Products Corporation and Wyeth. His work in these organizations has allowed him to explore and develop groundbreaking hormonal treatments that have potential applications in various medical fields.

Collaborations

Kees has collaborated with notable colleagues, including John H Musser and Diane Barbara Hauze. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Kenneth L Kees stands out as a significant figure in the realm of hormonal research, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing medical science. His work continues to influence the field and pave the way for future discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…